[ET Net News Agency, 16 October 2019] Hansoh Pharmaceutical Group Company Limited
(03692) said "fosaprepitant dimeglumine for injection" (product name "Tanneng") developed
by its subsidiary Jiangsu Hansoh Pharmaceutical Group Co., Ltd. has been granted drug
registration approval by the National Medical Products Administration of the People's
Republic of China and obtained approval for marketing.
Tanneng is used for the prevention of acute and delayed nausea and vomiting caused by
chemotherapy. (RC)